Latin America Platelet Rich Plasma (prp) Market Size & Outlook
Latin America platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Latin America platelet rich plasma (prp) market highlights
- The Latin America platelet rich plasma (prp) market generated a revenue of USD 40.8 million in 2023.
- The market is expected to grow at a CAGR of 15.9% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 40.8 million |
| Market revenue in 2030 | USD 114.6 million |
| Growth rate | 15.9% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.3% of the global platelet rich plasma (prp) market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.
Pure prp was the largest segment with a revenue share of 50.74% in 2023. Horizon Databook has segmented the Latin America platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is witnessing increasing attention and fast growth of PRP therapies. Scientists from several Latin American countries, such as Mexico, Uruguay, Chile, Brazil, and Argentina, are conducting R&D on novel PRP treatments & tools, such as PRP preparation kits & injections, boosting the adoption of these therapies in the region.
However, all Latin American countries are facing regulatory issues and related complications. This may hamper the market for PRP therapies. According to the study published in 2019, no information is available regarding the approval of PRP devices and directives. Thus, there is still a need for a more detailed document for production protocol.
However, in August 2018, the 4th Latin American Congress of Musculoskeletal Medicine was held in Argentina. Medical professionals from Brazil participated in it to present PRP therapies. Such conferences are anticipated to support market growth in the coming years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)
Latin America Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
